Joel C. Silverfield

Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial

Roy Fleischmann, Eduardo Mysler, Stephen Hall et al. · The Lancet · 2017 · 496 citations

Medicine, Pharmacology, Pharmacotherapy +12

Safety and efficacy of tofacitinib for up to 9.5 years in the treatment of rheumatoid arthritis: final results of a global, open-label, long-term extension study

J. Wollenhaupt, Eun-Bong Lee, Jeffrey R. Curtis et al. · Arthritis Research & Therapy · 2019 · 320 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +15

The effect of tofacitinib on pneumococcal and influenza vaccine responses in rheumatoid arthritis

Kevin Winthrop, Joel C. Silverfield, Arthur Racewicz et al. · Annals of the Rheumatic Diseases · 2015 · 195 citations · Full text

Veterinary Medicine, Immunology, Pharmacotherapy +17

Rheumatoid vasculitis: survival and associated risk factors.

Randall S. Vollertsen, Doyt L. Conn, David Ballard et al. · PubMed · 1986 · 117 citations

Medicine, Clinical Sciences, Internal Medicine +15

Tramadol/acetaminophen combination tablets for the treatment of osteoarthritis flare pain: a multicenter, outpatient, randomized, double-blind, placebo-controlled, parallel-group, add-on study

Joel C. Silverfield, Marc Kamin, Shu‐Chen Wu et al. · Clinical Therapeutics · 2002 · 106 citations

Nursing, Clinical Pharmacy, Pharmacotherapy +16